Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme
Ruth E. Langley, Duncan C. Gilbert, Trinh Duong, Noel W. Clarke, Matthew Nankivell, Stuart D. Rosen, Stephen Mangar, Archie Macnair, S.K. Sundaram, Marc Laniado, Sanjay Dixit, Sanjeev Madaan, Caroline Manetta, A. Pope, Christopher Scrase, Stephen McKay, Iqtedar A Muazzam, Gerald N. Collins, Jane Worlding, S. Williams, Edgar Páez, Angus Robinson, Jonathan McFarlane, John V Deighan, J. Jeffrey Marshall, Silvia Forcat, Melanie Weiß, Roger Kockelbergh, Abdulla Alhasso, Howard Kynaston, Mahesh Parmar
Topics & Concepts
MedicineTransdermalProstate cancerProstateAndrogenAndrogen suppressionOncologyInternal medicineUrologyHormoneEndocrinologyGynecologyCancerPharmacologyProstate Cancer Treatment and ResearchCancer, Lipids, and MetabolismChemotherapy-induced cardiotoxicity and mitigation